Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07927413

Effectiveness and Safety of TachoSil® Fibrin Sealant Patch for Supporting Dural Sealing Among Adult Inpatients

Conditions: Cerebrospinal Fluid (CSF) Leak, Psuedomeningocele

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 600
Sponsor: Corza Medical GmbH

Location: Johns Hopkins University Baltimore Maryland

Summary

This retrospective observational cohort study compares the effectiveness and safety of adjunctive TachoSil® fibrin sealant patch with DuraSeal® hydrogel sealant for supporting dural sealing in adult patients undergoing cranial or spinal surgery at participating United States hospitals. Medical records will be reviewed to assess clinically evident cerebrospinal fluid leak or clinically evident pseudomeningocele within 90 days after surgery. The study will use 1:1 propensity score matching to evaluate whether TachoSil® is non-inferior to DuraSeal® and will assess additional effectiveness and safety outcomes.

Eligibility Criteria

Inclusion Criteria: * Aged ≥ 18 years * Had an inpatient encounter to select sites with a cranial or spinal neurological surgery that involves dural sealing performed and discharged during January 1, 2017, and March 31, 2026 * Had use of TachoSil® or DuraSeal® sealants during the cranial or spinal neurological surgery as supportive dural sealing method Note: Any surgery meeting the above criteria is considered index surgery Exclusion Criteria: * Index surgery was trauma-related * Had an infection within 7 days prior to index date * Had any neurosurgery involving dural opening during the 12-month look-back period * Had neoplasm of dura mater/meningioma, requiring resection of dura during index visit (the earliest visit meeting selection criteria) or 12-month look-back period * Was pregnant at index visit * Had a CSF leak during the 12-month look-back period * If the surgical approach was transbasal or transpetrosal, if the arachnoid membrane and CSF- containing system remained intact, or if there was \>1 dura opening (excluding extra ventricular or lumbar drains) during index surgery * Had use of Evarrest patch, Tisseel, Adherus, CraniSeal, Duragen, fibrin glue or other dural sealing products during index surgery * Had radiation therapy to surgical field in the 3 months prior to index date * Had chronic corticosteroid use in the 3 months prior to index date * Had both TachoSil® and DuraSeal® used for dural closure during index neurological surgery

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07927413). StuddyBuddy aggregates publicly available trial information.